Design and baseline characteristics of FINE-HEART: an integrated pooled analysis of finerenone in >19,000 participants across 3 phase III trials of HF & CKD
13 May 2024 (09:06 - 09:14)
Organised by: 
Slides
About the speaker
Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
9 More presentations in this session
Professor S. von Haehling (Goettingen, DE)
Professor M. Petrie (Glasgow, GB)
Access the full session
The Event
Heart Failure 2024
13 May 2024
09:06 CET
You may be interested in
Congress Presentation
Congress Presentation
